Similar Papers

Paper Title
Journal
Date
Author
Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients
Osteoporosis International | VOL. 26
13 Nov 2014
Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis
Giuseppe Murdaca ... Francesco Puppo
Expert Opinion on Drug Safety | VOL. 12
Giuseppe Murdaca, et. al.Giuseppe Murdaca ... Francesco Puppo
29 Jul 2013
AB0111 THE COMPARISON OF SYNDECAN-4 LEVEL IN SERA, SYNOVIAL FLUID AND SYNOVIUM OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
J Zhao ... X Ye
-
J Zhao, et. al.J Zhao ... X Ye
01 Jun 2020
Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
Joo-Hyun Lee ... Yoon-Kyoung Sung
The Korean journal of internal medicine | VOL. 29
Joo-Hyun Lee, et. al.Joo-Hyun Lee ... Yoon-Kyoung Sung
01 Jan 2014
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor - 2025.
Josef Smolen
Annals of the rheumatic diseases | VOL. 84
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis.
Francis Berenbaum ... Marc Buyse
Annals of the rheumatic diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.